AIG
OLMA icon

American International Group’s Olema Pharmaceuticals OLMA Stock Holding History

American International Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,231
Closed -$150K – 1859
2024
Q1 		$150K Sell
13,231
-114
-0.9% -$1.47K ﹤0.01% 2304
2023
Q4 		$187K Sell
13,345
-54
-0.4% -$726 ﹤0.01% 2205
2023
Q3 		$165K Buy
13,399
+477
+4% +$4.86K ﹤0.01% 2228
2023
Q2 		$117K Buy
+12,922
New +$78K ﹤0.01% 2477
2022
Q2 		– Sell
-12,739
Closed -$54K – 3215
2022
Q1 		$54K Sell
12,739
-649
-5% -$3.58K ﹤0.01% 2818
2021
Q4 		$125K Sell
13,388
-402
-3% -$8.33K ﹤0.01% 2621
2021
Q3 		$380K Buy
13,790
+6,994
+103% +$189K ﹤0.01% 2024
2021
Q2 		$190 Sell
6,796
-274
-4% -$7.8K ﹤0.01% 2538
2021
Q1 		$235 Buy
+7,070
New +$303K ﹤0.01% 2286

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

American International Group's OLMA Position: Q2 2024 in Review

American International Group sold out of Olema Pharmaceuticals (OLMA) in Q2 2024, closing a stake of 13,231 shares — an estimated $150K sold.

American International Group first reported a position in OLMA in Q1 2021 and held it in 9 quarters. The position peaked at $380K in Q3 2021. 128 funds tracked by Wall St. Rank hold OLMA as of Q2 2024.

  • American International Group reported no remaining Olema Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 13,231 Olema Pharmaceuticals shares in Q2 2024, an estimated $150K.
  • American International Group first reported a position in Olema Pharmaceuticals in Q1 2021 and held it in 9 quarters.
  • American International Group's Olema Pharmaceuticals position peaked at $380K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.